Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24−/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

Mateusz Opyrchal(Indiana University Health), Antonino B. D’Assoro(Mayo Clinic)
International Journal of Oncology
June 25, 2014
10.3892/ijo.2014.2523
Cited by 52

Related Papers

NOTCH3 expression is linked to breast cancer seeding and distant metastasis
|Breast Cancer Research|2018|84
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors
|Cancers|2024|13
Abstract B109: Oral dual PI3K/mTOR inhibitor bimiralisib demonstrates tolerability and a signal of activity in head and neck squamous cell cancer with NOTCH1 loss-of-function mutation
|Molecular Cancer Therapeutics|2019|7